Trauma and Non-Trauma Therapies

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/269

encourage image

There's no tags or description

Looks like no tags are added yet.

270 Terms

1
New cards

What are the main outcomes used to evaluate clinical interventions?

Symptoms

Distress

Functional impairment

Quality of life

2
New cards

What is the key conclusion about psychotherapy from neuroimaging studies?

Psychotherapy is associated with measurable changes in brain activity, demonstrating that psychological treatment can produce biological effects.

3
New cards

What do increases vs. decreases in brain activity after therapy indicate?

Increase (increment): Greater activation in certain brain regions after treatment

Decrease (decrement): Reduced activation, often reflecting improved regulation or reduced symptom-related activity

4
New cards

What does the "combined" analysis represent in the figure?

It integrates results from both resting-state and task-based studies to identify overall patterns of neural change after psychotherapy.

5
New cards

What has research found about differences in treatment outcomes between clinicians?

There is significant variability in outcomes between clinicians treating similar clients.

6
New cards

How do clinician differences compare to differences between treatment types?

Differences between clinicians are often greater than differences between the types of treatments they use.

7
New cards

How is the therapeutic alliance related to outcome variability?

The strength of the therapeutic alliance varies between clinicians and is strongly associated with treatment outcomes.

8
New cards

What remains unclear about between-clinician differences in outcomes?

Researchers have not yet clearly identified the specific mediating variables (mechanisms) that explain why some clinicians achieve better outcomes than others.

9
New cards

How do some theorists view the therapeutic alliance in treatment?

They consider it the primary curative factor that is sufficient on its own to produce positive outcomes.

10
New cards

What is the middle position on the role of therapeutic alliance?

The therapeutic alliance is necessary but not sufficient, meaning it is required for good outcomes but must be combined with effective techniques.

11
New cards

Why do some researchers argue the therapeutic alliance may not be necessary?

Positive outcomes can occur in treatments with minimal or no therapist relationship, such as:

Self-help interventions

Computer-based therapy

12
New cards

What is the main debate about therapeutic alliance in psychotherapy?

Whether the therapeutic alliance is:

Sufficient,

Necessary but insufficient, or

Not necessary for treatment success.

13
New cards

Which therapist relational factors are considered demonstrably effective for improving outcomes?

Therapeutic alliance

Group cohesion

Empathy

Goal consensus and collaboration

14
New cards

Which therapist behaviors are considered probably effective?

Positive regard

Genuineness

Providing feedback

Repairing alliance ruptures

Self-disclosure

Managing countertransference

Accurate relational interpretations

15
New cards

What is countertransference management?

The therapist's ability to recognize and regulate their own emotional reactions to the client to maintain effective treatment.

16
New cards

Why are quality and timing more important than quantity of therapist behaviors?

The effectiveness of interventions depends on how skillfully and when they are delivered, not simply how often they occur.

17
New cards

What is an alliance rupture, and why is repair important?

An alliance rupture is a breakdown in the therapist-client relationship (e.g., conflict or misunderstanding); repairing it helps restore trust and improve treatment outcomes.

18
New cards

What patient characteristics are important for predicting treatment outcomes?

Stage of change

Coping style

Resistance level

Preference for treatment focus or modality

19
New cards

What is meant by a patient's stage of change?

The person's readiness to modify behavior (e.g., precontemplation, contemplation, action).

20
New cards

Why is coping style important in treatment planning?

Different coping styles (e.g., avoidant vs. problem-focused) influence how patients respond to specific interventions.

21
New cards

What does resistance level refer to in therapy?

The degree to which a patient resists or pushes back against therapeutic guidance or change.

22
New cards

Why is patient preference for treatment modality important?

Matching treatment to patient preferences can improve engagement, adherence, and outcomes.

23
New cards

How does diagnosis compare to patient characteristics in predicting treatment effects?

Diagnosis is often less predictive of treatment success than individual patient factors like readiness, coping style, and preferences.

24
New cards

What is Prochaska & DiClemente's Stages of Change model?

A transdiagnostic model describing how people move through stages when changing behavior, regardless of diagnosis.

25
New cards

What characterizes the Pre-Contemplation stage?

Person is unaware of or resistant to change

Does not yet see the problem as serious

Clinician role: Increase insight and motivatio

26
New cards

What characterizes the Contemplation stage?

- Person is aware of the problem

- Weighing pros and cons of change

Clinician role: Encourage reflection and exploration of meaning (existential reflection)

27
New cards

What characterizes the Preparation stage?

- Person begins planning and organizing for change

- Takes initial small steps toward change

Clinician role: Help develop a concrete plan

28
New cards

What characterizes the Action stage?

- Person is actively engaged in behavior change

- Fully participating in treatment

Clinician role: Support and reinforce new behaviors

29
New cards

What characterizes the Maintenance stage?

- Focus on relapse prevention

- Continued growth and stability of new behaviors

Clinician role: Strengthen coping strategies and long-term habits

30
New cards

What helps individuals move through the stages of change?

Empathy

Support

31
New cards

What are the four general stages of psychodynamic therapy?

Confrontation - Bringing attention to problematic behaviors or feelings

Clarification - Helping the client better understand these experiences

Interpretation - Explaining underlying unconscious meanings

Working Through - Repeatedly exploring insights to produce lasting change

32
New cards

What is a primary behavioral goal of psychodynamic therapy?

To shift behavior from being guided by unconscious processes to being guided by conscious awareness.

33
New cards

How does insight lead to behavior change in psychodynamic therapy?

By bringing unconscious material into conscious awareness, allowing more consistent and intentional behavior.

34
New cards

What is catharsis in psychodynamic therapy?

The emotional release (abreaction) that provides therapeutic benefit and can create a corrective emotional experience.

35
New cards

What is meant by the therapist as a "blank slate" in psychodynamic therapy?

The therapist maintains neutrality and minimizes personal disclosure to allow the client to project thoughts and feelings onto them.

36
New cards

What is a holding environment (or container) in therapy?

A safe, supportive psychological space where clients can express difficult emotions and experiences.

37
New cards

What are key techniques used in psychodynamic therapy?

Free association

Dream interpretation

Analysis of Transference

Counter-Transference

38
New cards

Repression

Most Basic; INvoluntary exclusion of memories/desires from consciousness into unconscious; akin to difficulties with retrieval not encoding

39
New cards

Suppression

Voluntary (volitional, wilful) exclusion of memories/desires from consciousness

40
New cards

Regression

To an earlier stage of development (e.g., oral/anal/phallic)

41
New cards

Projection

Transfer & then perceive undesirable aspects of ones own personality onto another person (transference: client-totherapist, counter-transference: therapist-to-client)

42
New cards

Reaction Formation

Exaggerated acting opposite to undesirable/rejected impulse

43
New cards

Sublimation

Conversion of undesirable impulse into acceptable one

44
New cards

Displacement

Conversion of undesirable impulse into less extreme form

45
New cards

Rationalization

Behaviour motivated by undesirable impulse explained as if by sensible terms

46
New cards

What are these examples of?

Psychodynamic defense mechanisms

47
New cards

What are the two main types of exposure used in Prolonged Exposure (PE)?

In vivo exposure (real-life situations)

Imaginal exposure (recounting the trauma aloud)

48
New cards

What learning mechanisms explain how Prolonged Exposure works?

Habituation

Extinction

Modification of fear structures

49
New cards

When is Prolonged Exposure contraindicated?

When there is high risk of:

Suicide

Homicide

Self-injury

Severe retraumatization

50
New cards

What memory ability is required for Prolonged Exposure?

The client must have a clear memory of the trauma.

51
New cards

What is the central idea behind Cognitive Processing Therapy (CPT)?

A person's interpretation of the traumatic event determines their emotional reaction.

52
New cards

What are the three belief-change processes in CPT?

Assimilation: Change memory to fit beliefs

Accommodation: Adjust beliefs to fit reality (goal of treatment)

Over-accommodation: Extreme belief change (e.g., "No one can be trusted")

53
New cards

What five belief areas are targeted in CPT (SPITE)?

Safety

Power & Control

Intimacy

Trust

Esteem

54
New cards

Is writing a trauma narrative required in CPT?

Not necessarily—research suggests a written narrative may not be required for effectiveness.

55
New cards

What is the main procedure in EMDR?

The client holds the traumatic memory in mind while engaging in bilateral stimulation (e.g., eye movements or tapping).

56
New cards

What mechanisms are proposed to explain EMDR?

Saccadic eye movements

Interhemispheric processing

Possible distraction effects

57
New cards

How structured is EMDR compared to other trauma therapies?

It is less structured and relies more on associative memory processing.

58
New cards

What is the main focus of each therapy?

PE: Exposure to trauma memories and situations

CPT: Changing trauma-related beliefs

EMDR: Processing memories with bilateral stimulation

59
New cards

What is psilocybin?

A naturally occurring plant alkaloid and the primary active ingredient in "magic mushrooms" that produces psychedelic effects.

60
New cards

How does psilocybin affect the brain?

It binds strongly to 5-HT2A serotonin receptors, producing psychedelic effects and altering perception and mood.

61
New cards

How might psilocybin's action differ from traditional antidepressants?

Psilocybin activates (agonist) 5-HT2A receptors, whereas many antidepressants may have antagonist or indirect effects on these receptors.

62
New cards

What have previous studies found about psilocybin as a treatment for depression?

At least four studies found psilocybin effective for treating depression when used alongside psychotherapy.

63
New cards

What is treatment-resistant depression (TRD)?

Depression that does not improve after adequate trials of standard treatments (e.g., antidepressants).

64
New cards

What was the goal of the follow-up psilocybin study?

To replicate earlier findings with:

A larger sample (20 participants, up from 12)

A longer follow-up period (6 months)

65
New cards

What is the key implication of this introduction section?

Psilocybin-assisted psychotherapy shows promise as a treatment for depression, including treatment-resistant cases, with evidence of sustained effects over time.

66
New cards

What type of study design was used in the psilocybin trial?

An open-label feasibility study involving 20 patients with treatment-resistant depression (TRD).

67
New cards

What dosing schedule was used in the psilocybin study?

Two oral doses:

10 mg (initial dose)

25 mg (high dose)

Given 7 days apart.

68
New cards

What was the primary outcome measured in the study?

Self-reported depressive symptoms following the high-dose session.

69
New cards

When were depressive symptoms assessed after the high-dose session?

1-3 weeks

5 weeks

3 months

6 months

70
New cards

How was treatment-resistant depression defined for participant inclusion?

Participants had to remain at least moderately depressed despite trying two different antidepressants for at least 6 weeks during the current episode.

71
New cards

What medication change was required before participating in the study?

Participants had to taper off their antidepressants prior to the trial.

72
New cards

What major condition excluded participants from the study?

A personal or family history of psychotic disorder.

73
New cards

What is the purpose of the Preparation-Support-Integration (PSI) model in psychedelic therapy?

To structure therapeutic care before, during, and after the psychedelic experience to maximize safety, trust, and long-term psychological benefit.

74
New cards

What occurs during the Preparation phase of psychedelic therapy?

Building trust and rapport

Getting to know the client

Providing information about the treatment and experience

Goal: Establish safety and readiness.

75
New cards

What occurs during the Support phase of psychedelic therapy?

Empathic listening

Reassurance

Emotional presence during the psychedelic session

Goal: Maintain psychological safety during the experience.

76
New cards

What occurs during the Integration phase of psychedelic therapy?

Nonjudgmental listening

Interpretation of the experience

Guidance or advice for applying insights to daily life

Goal: Translate the experience into lasting behavioral or cognitive change.

77
New cards

What were the key demographic characteristics of participants in the resistent depression psilocybin study?

The majority were:

Male (14/20)

Caucasian (15/20)

Highly educated (18/20)

Previously received psychotherapy (17/20)

Severely depressed (18/20)

78
New cards

What were notable background characteristics of participants?

About half were unemployed (11/20)

About one-third had previously used psilocybin (7/20)

79
New cards

What important clinical information was not reported in the study?

Trauma type

Comorbidity diagnoses (DSM/ICD)

80
New cards

What Research Domain Criteria (RDoC) construct was specifically assessed?

Anhedonia (loss of pleasure).

81
New cards

What pattern was observed in depressive symptoms after psilocybin treatment?

Depression decreased, with the maximum improvement at 5 weeks.

82
New cards

What other mental health outcomes improved after treatment?

Anxiety: Reduced at 1 week, 3 months, and 6 months

Anhedonia: Reduced at 1 week and 3 months

Suicidality: Reduced at 1 week and 2 weeks

83
New cards

What relapse pattern was observed among responders?

3 of 9 responders relapsed within 6 months.

84
New cards

What were the most common side effects reported?

Transient anxiety (most common; short-lived)

Headaches (1-2 days)

Nausea

Brief paranoia

85
New cards

What participant exclusions did the authors suggest for future psilocybin studies?

Consider excluding individuals with:

Personality disorders

Prior safe exposure to psilocybin

86
New cards

What notable behavior occurred after the study ended?

Five participants sought additional psilocybin treatment, suggesting perceived benefit or continued interest

87
New cards

How were the subjective effects of psilocybin measured in the study?

Using the 11D-ASC (Altered States of Consciousness) survey, which assesses different dimensions of psychedelic experiences.

88
New cards

Why were subjective effects compared between the 10 mg and 25 mg doses?

To determine whether higher doses produce stronger psychological experiences and whether these relate to treatment outcomes.

89
New cards

What type of experiences did many participants report during psilocybin sessions?

The majority (14/20) reported autobiographical visions, often involving past memories or emotionally significant events.

90
New cards

What example illustrates possible short-term distress during psilocybin treatment?

One patient experienced a distressing vision involving their father, leading to temporary worsening of depression, which later improved.

91
New cards

Which experiences were reported to be stronger after the higher (25 mg) dose?

Unity

Spiritual experiences

Blissful states

Insightfulness

Complex imagery

92
New cards

How were certain subjective experiences related to depression outcomes?

Greater experiences of unity, spirituality, bliss, and insight during the high-dose session were associated with greater depression reduction at 5 weeks.

93
New cards

What theory explains how psilocybin may improve depression?

Psilocybin may induce a temporary state of increased neural plasticity, allowing maladaptive cognitive patterns linked to depression to be modified.

94
New cards

What is the key clinical implication of these findings?

The quality and intensity of the psychedelic experience—not just the drug itself—may play a critical role in therapeutic improvement.

95
New cards

What major methodological strength did the psilocybin study have?

It measured both:

Psychological outcomes (self-report symptoms)

Neurobiological outcomes (fMRI brain imaging)

96
New cards

What limitation applied to the neurobiological (fMRI) findings?

The results were reported in a separate article, limiting direct integration with the main study findings.

97
New cards

What important clinical variables were not assessed or reported?

Trauma history

Comorbidity

98
New cards

Why is an open-label design without a control group a weakness?

It makes it difficult to determine whether improvements were due to:

The treatment itself

Placebo effects

Expectancy effects

Natural recovery

99
New cards

Why were the demographics considered a weakness?

The sample was not representative of the general population, limiting generalizability of the findings.

100
New cards

What additional limitation related to demographics was noted?

Researchers did not analyze whether demographic factors (e.g., education, prior therapy) influenced treatment response.